BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 18508999)

  • 1. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
    de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
    Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogens upregulate estrogen receptor beta expression and inhibit adrenocortical H295R cell proliferation.
    Montanaro D; Maggiolini M; Recchia AG; Sirianni R; Aquila S; Barzon L; Fallo F; Andò S; Pezzi V
    J Mol Endocrinol; 2005 Oct; 35(2):245-56. PubMed ID: 16216906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of ERalpha, ERbeta and PR in lobular carcinoma in situ of the breast determined using laser microdissection and real-time PCR.
    Green AR; Young P; Krivinskas S; Rakha EA; Claire Paish E; Powe DG; Ellis IO
    Histopathology; 2009 Mar; 54(4):419-27. PubMed ID: 19309393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
    Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex steroid receptors in rheumatoid arthritis.
    Ishizuka M; Hatori M; Suzuki T; Miki Y; Darnel AD; Tazawa C; Sawai T; Uzuki M; Tanaka Y; Kokubun S; Sasano H
    Clin Sci (Lond); 2004 Mar; 106(3):293-300. PubMed ID: 14570589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal mapping and quantitative analysis of estrogen-related receptor alpha-1, estrogen receptors alpha and beta and progesterone receptor in the bovine mammary gland.
    Connor EE; Wood DL; Sonstegard TS; da Mota AF; Bennett GL; Williams JL; Capuco AV
    J Endocrinol; 2005 Jun; 185(3):593-603. PubMed ID: 15930184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA and kinetic heterogeneity during the clonal evolution of adrenocortical proliferative lesions.
    Blanes A; Diaz-Cano SJ
    Hum Pathol; 2006 Oct; 37(10):1295-303. PubMed ID: 16949934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of the microvessel network to the clonal and kinetic profiles of adrenal cortical proliferative lesions.
    Diaz-Cano SJ; de Miguel M; Blanes A; Galera H; Wolfe HJ
    Hum Pathol; 2001 Nov; 32(11):1232-9. PubMed ID: 11727263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomas.
    Soon PS; Gill AJ; Benn DE; Clarkson A; Robinson BG; McDonald KL; Sidhu SB
    Endocr Relat Cancer; 2009 Jun; 16(2):573-83. PubMed ID: 19218281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the mTOR pathway in human normal adrenal and adrenocortical tumors.
    De Martino MC; Feelders RA; de Herder WW; van Koetsveld PM; Dogan F; Janssen JA; Waaijers AM; Pivonello C; Lamberts SW; Colao A; de Krijger RR; Pivonello R; Hofland LJ
    Endocr Relat Cancer; 2014 Aug; 21(4):601-13. PubMed ID: 24891456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of aromatase and estrogen receptors in human adrenocortical tumors.
    Barzon L; Masi G; Pacenti M; Trevisan M; Fallo F; Remo A; Martignoni G; Montanaro D; Pezzi V; Palù G
    Virchows Arch; 2008 Feb; 452(2):181-91. PubMed ID: 18157729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Messenger RNA levels of estrogen receptors alpha and beta and progesterone receptors in the cyclic and inseminated/early pregnant sow uterus.
    Sukjumlong S; Persson E; Dalin AM; Janson V; Sahlin L
    Anim Reprod Sci; 2009 Jun; 112(3-4):215-28. PubMed ID: 18547755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors.
    Barzon L; Pacenti M; Masi G; Stefani AL; Fincati K; Palù G
    Oncology; 2005; 68(4-6):414-21. PubMed ID: 16020971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot differences in steroid receptor expression in adipose tissue: possible role of the local steroid milieu.
    Rodriguez-Cuenca S; Monjo M; Proenza AM; Roca P
    Am J Physiol Endocrinol Metab; 2005 Jan; 288(1):E200-7. PubMed ID: 15367392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
    Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of estrogen and progesterone receptors in human prostatic tumors determined by quantitative real-time PCR.
    Ji Q; Liu PI; Elshimali Y; Stolz A
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):103-10. PubMed ID: 15607534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocorticotropic hormone-independent Cushing's syndrome.
    Bourdeau I; Lampron A; Costa MH; Tadjine M; Lacroix A
    Curr Opin Endocrinol Diabetes Obes; 2007 Jun; 14(3):219-25. PubMed ID: 17940443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin in adrenocortical tumors - pathophysiological implications and therapeutic potential.
    Sbiera S; Kroiss M; Thamm T; Beyer M; Majidi F; Kuehner D; Wobser M; Becker JC; Adam P; Ronchi C; Allolio B; Fassnacht M
    Horm Metab Res; 2013 Feb; 45(2):137-46. PubMed ID: 23143666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.